Wendell P. Weeks,Robert Anthony Schaut,Steven Edward DeMartino,John Stephen Peanasky
申请号：
US14965007
公开号：
US20160095795A1
申请日:
2015.12.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, LEVEMIR, NOVOLOG, NOVOLIN 70-30, NOVOLIN R, NOVOLIN N, NOVOLOG MIX 70-30 and NOVOLIN L.
